Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Top Republican on Senate health committee says he’s ‘struggling’ to confirm RFK Jr

by admin January 31, 2025
January 31, 2025
Top Republican on Senate health committee says he’s ‘struggling’ to confirm RFK Jr

The top Republican on the Senate’s chief health committee, Sen. Bill Cassidy, R-La., indicated Thursday during Robert F. Kennedy Jr.’s second confirmation hearing of the week that his vote for Trump’s nominee to head Health and Human Services was not a lock, noting that he was ‘struggling’ to confirm Kennedy over his inability to admit vaccines are safe and don’t cause autism.

Kennedy faced two separate hearings in front of Senate lawmakers this week in his bid to be the next secretary of the Department of Health and Human Services. Kennedy was probed frequently over his views on vaccines, which have been a sticking point for many senators as they figure out whether to vote in favor of Kennedy’s nomination or not.

During the hearings, Kennedy refused to reject claims he has posited publicly in the past that vaccines cause autism and argued he is not anti-vaccine but rather ‘pro-safety.’ Kennedy added during the hearings that his plan as HHS secretary would be to ‘follow the science,’ noting that if the science says he is wrong on vaccines, he will publicly apologize. 

But senators, like Cassidy, have suggested during Kennedy’s confirmation hearings that the science says vaccines are safe — and they don’t cause autism.

‘My responsibility is to learn, try and determine, if you can be trusted to support the best public health,’ Cassidy, a former physician, said during his closing remarks at Kennedy’s Thursday confirmation hearing in front of the Senate Committee on Health, Education, Labor and Pensions (HELP). ‘A worthy movement called ‘MAHA,’’ Cassidy continued, ‘to improve the health of Americans, or to undermine it, always asking for more evidence, and never accepting the evidence that is there … That is why I’ve been struggling with your nomination.’ 

Cassidy repeatedly asked Kennedy during the Thursday hearing to publicly declare that vaccines don’t cause autism, but he refused. ‘That would have an incredible impact,’ Cassidy said. 

‘There are issues we are, man, ultra-processed food, obesity, we are simpatico. We are completely aligned,’ Cassidy continued during his closing remarks. ‘And as someone who has discussed immunizations with thousands of people, I understand that mothers want reassurance that the vaccine their child is receiving is necessary, safe and effective. We agree on that point, the two of us, but we’ve approached it differently. And I think I can say that I’ve approached it using the preponderance of evidence to reassure, and you’ve approached it using selective evidence to cast doubt.’

Meanwhile, Cassidy pointed out the massive ‘megaphone’ Kennedy has as a descendant of former President John F. Kennedy, and questioned whether he will use his credibility ‘to support’ or ‘to undermine’ the nation’s public health and its confidence in vaccines.

‘I got to figure that out, for my vote,’ Cassidy said.

This post appeared first on FOX NEWS

previous post
Kash Patel turns tables on Dem senator with viral response: ‘You’ve got two minutes’
next post
Birthright citizenship: Why the ‘right of soil’ is so big in the Americas

Related Posts

Trump rattles off ‘flagrant scams’ uncovered by DOGE,...

February 23, 2025

Trump, Putin agree to begin ceasefire negotiations in...

March 19, 2025

NASA astronauts stranded in space due to Biden’s...

March 20, 2025

Rubio makes progress with Russia after Trump promised...

February 19, 2025

‘Truly providential’: Trump made promise to Marc Fogel’s...

February 14, 2025

CIA director blasts Democrat’s ‘offensive line of questioning’...

March 27, 2025

Trump inauguration performer Gavin DeGraw salutes ‘businessman running...

January 23, 2025

Task force to expose ‘federal secrets’ on JFK...

February 19, 2025

DAVID MARCUS: Radical transparency is the secret to...

February 24, 2025

Feds accused of destroying Epstein evidence put on...

March 15, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved